Review



ciap1 gene  (Imoto Machinery Co)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Imoto Machinery Co ciap1 gene
    Ciap1 Gene, supplied by Imoto Machinery Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ciap1+gene/c+iap1+target+gene/pm32585232-57-4-30
    Average 90 stars, based on 1 article reviews
    ciap1 gene - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: The Multiple Roles of the IAP Super-family in cancer.
    Article Snippet: They found that only cIAP1 was consistently over-amplified in the cell lines and also found it to be overexpressed in the primary tumors from which these cell lines were derived (Imoto, et al., 2001).

    Derivative Assay:

    Article Title: CIAP1 and the serine protease HTRA2 are involved in a novel p53-dependent apoptosis pathway in mammals
    Article Snippet: .. The deregulation of IAPs has been reported in cancers, for example; IAPs are overexpressed in cell lines derived from a variety of leukemias, lymphomas, and other cancers ( Tamm et al. 2000 ); and the CIAP1 gene is amplified in esophageal squamous cell carcinomas ( Imoto et al. 2001 ). ..

    Amplification:

    Article Title: CIAP1 and the serine protease HTRA2 are involved in a novel p53-dependent apoptosis pathway in mammals
    Article Snippet: .. The deregulation of IAPs has been reported in cancers, for example; IAPs are overexpressed in cell lines derived from a variety of leukemias, lymphomas, and other cancers ( Tamm et al. 2000 ); and the CIAP1 gene is amplified in esophageal squamous cell carcinomas ( Imoto et al. 2001 ). ..



    Similar Products

    small interfering rnas (sirnas) targeting genes fmr1, ciap1, ciap2, chip  (Bioneer Corporation)
    90
    Bioneer Corporation small interfering rnas (sirnas) targeting genes fmr1, ciap1, ciap2, chip
    Small Interfering Rnas (Sirnas) Targeting Genes Fmr1, Ciap1, Ciap2, Chip, supplied by Bioneer Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ciap1+gene/small+interfering+rnas++sirnas+/pm39693941-125-3-20
    Average 90 stars, based on 1 article reviews
    small interfering rnas (sirnas) targeting genes fmr1, ciap1, ciap2, chip - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    ciap1 gene  (SAS institute)
    90
    SAS institute ciap1 gene
    Identification of the <t>cIAP1</t> gene as a miR-634 direct target (A) Induction of apoptotic cell death by overexpression of miR-634 in SAS and Ca9-22 cells. Cells were evaluated at day 2 after transfection with 20 nM miR-NC or miR-634 . Upper: phase-contrast images in the miRNA-transfected cells. Scale bars: 20 μm. Lower: FACS analysis of the apoptotic cell population. (B) Western blot analysis of the miRNA-transfected cells. Cell lysates were prepared two days after transfection. (C) Identification of miR-634 target genes by RIP-Chip analysis in SAS and A431 cells. In total, 3,491 and 1,459 genes were identified as the candidates with a fold change (FC) > 2.0 by RIP-Chip analysis in SAS and A431 cells, respectively; 1,313 genes identified by both analyses were defined as the miR-634 target genes. (D) RIP-PCR analysis of the cIAP1 gene. Enrichment relative to IgG immunoprecipitation in miR-NC -transfected cells is presented. (E) Western blot analysis of cIAP1 in the miRNA-transfected cells. (F) The positions of two putative miR-634 binding sites (site 1; S1 and site 2; S2) within the coding region of the cIAP1 gene (accession No. NM_001166 ; 3,764 bp) are indicated. (G) Luciferase assay using reporter plasmids. Seed sequences of miR-634 and its mutant sequences are indicated. SAS cells were cotransfected with a reporter plasmid and an internal control vector, and after 5 h, either miR-NC or miR-634 was additionally transfected. Thirty-six hours after transfection, luciferase activity was measured. The luciferase activity in miR-634 -transfected cells relative to that in miR-NC -transfected cells is indicated on the vertical axis. In (A), (D), and (G), error bars indicate the SD of triplicate experiments, and data are presented as the mean ± SD. p values were calculated using the two-sided Student's t test (A and D) or one-way ANOVA (G). ∗p < 0.0001, ∗∗p < 0.005. NS, not significant.
    Ciap1 Gene, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ciap1+gene/ciap+1+protein/pmc09073396-20-6-29
    Average 90 stars, based on 1 article reviews
    ciap1 gene - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    ciap1 gene  (Imoto Machinery Co)
    90
    Imoto Machinery Co ciap1 gene
    Identification of the <t>cIAP1</t> gene as a miR-634 direct target (A) Induction of apoptotic cell death by overexpression of miR-634 in SAS and Ca9-22 cells. Cells were evaluated at day 2 after transfection with 20 nM miR-NC or miR-634 . Upper: phase-contrast images in the miRNA-transfected cells. Scale bars: 20 μm. Lower: FACS analysis of the apoptotic cell population. (B) Western blot analysis of the miRNA-transfected cells. Cell lysates were prepared two days after transfection. (C) Identification of miR-634 target genes by RIP-Chip analysis in SAS and A431 cells. In total, 3,491 and 1,459 genes were identified as the candidates with a fold change (FC) > 2.0 by RIP-Chip analysis in SAS and A431 cells, respectively; 1,313 genes identified by both analyses were defined as the miR-634 target genes. (D) RIP-PCR analysis of the cIAP1 gene. Enrichment relative to IgG immunoprecipitation in miR-NC -transfected cells is presented. (E) Western blot analysis of cIAP1 in the miRNA-transfected cells. (F) The positions of two putative miR-634 binding sites (site 1; S1 and site 2; S2) within the coding region of the cIAP1 gene (accession No. NM_001166 ; 3,764 bp) are indicated. (G) Luciferase assay using reporter plasmids. Seed sequences of miR-634 and its mutant sequences are indicated. SAS cells were cotransfected with a reporter plasmid and an internal control vector, and after 5 h, either miR-NC or miR-634 was additionally transfected. Thirty-six hours after transfection, luciferase activity was measured. The luciferase activity in miR-634 -transfected cells relative to that in miR-NC -transfected cells is indicated on the vertical axis. In (A), (D), and (G), error bars indicate the SD of triplicate experiments, and data are presented as the mean ± SD. p values were calculated using the two-sided Student's t test (A and D) or one-way ANOVA (G). ∗p < 0.0001, ∗∗p < 0.005. NS, not significant.
    Ciap1 Gene, supplied by Imoto Machinery Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ciap1+gene/c+iap1+target+gene/pm32585232-57-4-30
    Average 90 stars, based on 1 article reviews
    ciap1 gene - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    ciap1 target gene  (Imoto Machinery Co)
    90
    Imoto Machinery Co ciap1 target gene
    Identification of the <t>cIAP1</t> gene as a miR-634 direct target (A) Induction of apoptotic cell death by overexpression of miR-634 in SAS and Ca9-22 cells. Cells were evaluated at day 2 after transfection with 20 nM miR-NC or miR-634 . Upper: phase-contrast images in the miRNA-transfected cells. Scale bars: 20 μm. Lower: FACS analysis of the apoptotic cell population. (B) Western blot analysis of the miRNA-transfected cells. Cell lysates were prepared two days after transfection. (C) Identification of miR-634 target genes by RIP-Chip analysis in SAS and A431 cells. In total, 3,491 and 1,459 genes were identified as the candidates with a fold change (FC) > 2.0 by RIP-Chip analysis in SAS and A431 cells, respectively; 1,313 genes identified by both analyses were defined as the miR-634 target genes. (D) RIP-PCR analysis of the cIAP1 gene. Enrichment relative to IgG immunoprecipitation in miR-NC -transfected cells is presented. (E) Western blot analysis of cIAP1 in the miRNA-transfected cells. (F) The positions of two putative miR-634 binding sites (site 1; S1 and site 2; S2) within the coding region of the cIAP1 gene (accession No. NM_001166 ; 3,764 bp) are indicated. (G) Luciferase assay using reporter plasmids. Seed sequences of miR-634 and its mutant sequences are indicated. SAS cells were cotransfected with a reporter plasmid and an internal control vector, and after 5 h, either miR-NC or miR-634 was additionally transfected. Thirty-six hours after transfection, luciferase activity was measured. The luciferase activity in miR-634 -transfected cells relative to that in miR-NC -transfected cells is indicated on the vertical axis. In (A), (D), and (G), error bars indicate the SD of triplicate experiments, and data are presented as the mean ± SD. p values were calculated using the two-sided Student's t test (A and D) or one-way ANOVA (G). ∗p < 0.0001, ∗∗p < 0.005. NS, not significant.
    Ciap1 Target Gene, supplied by Imoto Machinery Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ciap1+gene/c+iap1+target+gene/pm15126108-127-17-18
    Average 90 stars, based on 1 article reviews
    ciap1 target gene - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Identification of the cIAP1 gene as a miR-634 direct target (A) Induction of apoptotic cell death by overexpression of miR-634 in SAS and Ca9-22 cells. Cells were evaluated at day 2 after transfection with 20 nM miR-NC or miR-634 . Upper: phase-contrast images in the miRNA-transfected cells. Scale bars: 20 μm. Lower: FACS analysis of the apoptotic cell population. (B) Western blot analysis of the miRNA-transfected cells. Cell lysates were prepared two days after transfection. (C) Identification of miR-634 target genes by RIP-Chip analysis in SAS and A431 cells. In total, 3,491 and 1,459 genes were identified as the candidates with a fold change (FC) > 2.0 by RIP-Chip analysis in SAS and A431 cells, respectively; 1,313 genes identified by both analyses were defined as the miR-634 target genes. (D) RIP-PCR analysis of the cIAP1 gene. Enrichment relative to IgG immunoprecipitation in miR-NC -transfected cells is presented. (E) Western blot analysis of cIAP1 in the miRNA-transfected cells. (F) The positions of two putative miR-634 binding sites (site 1; S1 and site 2; S2) within the coding region of the cIAP1 gene (accession No. NM_001166 ; 3,764 bp) are indicated. (G) Luciferase assay using reporter plasmids. Seed sequences of miR-634 and its mutant sequences are indicated. SAS cells were cotransfected with a reporter plasmid and an internal control vector, and after 5 h, either miR-NC or miR-634 was additionally transfected. Thirty-six hours after transfection, luciferase activity was measured. The luciferase activity in miR-634 -transfected cells relative to that in miR-NC -transfected cells is indicated on the vertical axis. In (A), (D), and (G), error bars indicate the SD of triplicate experiments, and data are presented as the mean ± SD. p values were calculated using the two-sided Student's t test (A and D) or one-way ANOVA (G). ∗p < 0.0001, ∗∗p < 0.005. NS, not significant.

    Journal: Molecular Therapy Oncolytics

    Article Title: Potential for reversing miR-634 -mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma

    doi: 10.1016/j.omto.2022.02.002

    Figure Lengend Snippet: Identification of the cIAP1 gene as a miR-634 direct target (A) Induction of apoptotic cell death by overexpression of miR-634 in SAS and Ca9-22 cells. Cells were evaluated at day 2 after transfection with 20 nM miR-NC or miR-634 . Upper: phase-contrast images in the miRNA-transfected cells. Scale bars: 20 μm. Lower: FACS analysis of the apoptotic cell population. (B) Western blot analysis of the miRNA-transfected cells. Cell lysates were prepared two days after transfection. (C) Identification of miR-634 target genes by RIP-Chip analysis in SAS and A431 cells. In total, 3,491 and 1,459 genes were identified as the candidates with a fold change (FC) > 2.0 by RIP-Chip analysis in SAS and A431 cells, respectively; 1,313 genes identified by both analyses were defined as the miR-634 target genes. (D) RIP-PCR analysis of the cIAP1 gene. Enrichment relative to IgG immunoprecipitation in miR-NC -transfected cells is presented. (E) Western blot analysis of cIAP1 in the miRNA-transfected cells. (F) The positions of two putative miR-634 binding sites (site 1; S1 and site 2; S2) within the coding region of the cIAP1 gene (accession No. NM_001166 ; 3,764 bp) are indicated. (G) Luciferase assay using reporter plasmids. Seed sequences of miR-634 and its mutant sequences are indicated. SAS cells were cotransfected with a reporter plasmid and an internal control vector, and after 5 h, either miR-NC or miR-634 was additionally transfected. Thirty-six hours after transfection, luciferase activity was measured. The luciferase activity in miR-634 -transfected cells relative to that in miR-NC -transfected cells is indicated on the vertical axis. In (A), (D), and (G), error bars indicate the SD of triplicate experiments, and data are presented as the mean ± SD. p values were calculated using the two-sided Student's t test (A and D) or one-way ANOVA (G). ∗p < 0.0001, ∗∗p < 0.005. NS, not significant.

    Article Snippet: Among the 1,313 genes, we found cIAP1 , whose expression is involved in chemotherapeutic resistance, including CDDP (listed as BIRC2 in ; FC:5.22 in A431 cells and FC:10.01 in SAS cells).

    Techniques: Over Expression, Transfection, Western Blot, RNA Immunoprecipitation - Chromatin Immunoprecipitation, Immunoprecipitation, Binding Assay, Luciferase, Mutagenesis, Plasmid Preparation, Control, Activity Assay

    Enhancement of CDDP-induced cytotoxicity by miR-634 in OSCC cells (A) Cell survival assay. Cells were transfected with increasing doses of miR-634 (2.5–10 nM) and treated with CDDP (2.5–10 μM) for two days from the following day. The results are reported as the relative rate compared with miR-NC -transfected and non-treated cells. (B) FACS analysis of the apoptotic cell population among cells with miRNAs and/or CDDP. Cells were transfected with miRNAs (2.5 nM) and treated with CDDP for two days from the following day. (C) Western blot analysis of cleaved caspase-3 (cCasp-3) and cleaved PARP (cPARP) as the apoptosis markers and the miR-634 target genes. (D) FACS analysis of the apoptotic cell population. Cells were transfected with siRNAs (10 nM) and treated with CDDP for two days from the following day or were concurrently treated with AT406 (10 μM) and CDDP for two days. (E) Western blot analysis of apoptosis markers and cIAP1. In (A), (B), and (D), error bars indicate the SD of triplicate experiments, and data are presented as the mean ± SD. p values were calculated using the two-way ANOVA (A and B) and two-sided Student's t test (D). ∗p < 0.0001, ∗∗p < 0.005.

    Journal: Molecular Therapy Oncolytics

    Article Title: Potential for reversing miR-634 -mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma

    doi: 10.1016/j.omto.2022.02.002

    Figure Lengend Snippet: Enhancement of CDDP-induced cytotoxicity by miR-634 in OSCC cells (A) Cell survival assay. Cells were transfected with increasing doses of miR-634 (2.5–10 nM) and treated with CDDP (2.5–10 μM) for two days from the following day. The results are reported as the relative rate compared with miR-NC -transfected and non-treated cells. (B) FACS analysis of the apoptotic cell population among cells with miRNAs and/or CDDP. Cells were transfected with miRNAs (2.5 nM) and treated with CDDP for two days from the following day. (C) Western blot analysis of cleaved caspase-3 (cCasp-3) and cleaved PARP (cPARP) as the apoptosis markers and the miR-634 target genes. (D) FACS analysis of the apoptotic cell population. Cells were transfected with siRNAs (10 nM) and treated with CDDP for two days from the following day or were concurrently treated with AT406 (10 μM) and CDDP for two days. (E) Western blot analysis of apoptosis markers and cIAP1. In (A), (B), and (D), error bars indicate the SD of triplicate experiments, and data are presented as the mean ± SD. p values were calculated using the two-way ANOVA (A and B) and two-sided Student's t test (D). ∗p < 0.0001, ∗∗p < 0.005.

    Article Snippet: Among the 1,313 genes, we found cIAP1 , whose expression is involved in chemotherapeutic resistance, including CDDP (listed as BIRC2 in ; FC:5.22 in A431 cells and FC:10.01 in SAS cells).

    Techniques: Clonogenic Cell Survival Assay, Transfection, Relative Rate, Western Blot

    Overcoming CDDP resistance by miR-634 in OSCC cells (A) Western blot analysis of miR-634 target genes in RT7 cells and six OSCC cell lines. IC50 values (μM) for CDDP treatment for each cell line are indicated. (B) Quantitative genomic-PCR for the cIAP1 gene in OSCC cell lines. The copy number ratios are presented relative to the copy number in RT7 cells. (C) The correlation between copy number and the corresponding mRNA expression of the cIAP1 gene in 496 cases of HNSCC, including OSCC, from TCGA data. (D) FACS analysis of the apoptotic cell population among TSU cells. Cells were transfected with miRNAs (2.5 nM) and treated with CDDP for two days from the following day. (E) Western blot analysis of cleaved caspase-3 (cCasp-3) and cleaved PARP (cPARP) as the apoptosis markers, and the miR-634 target genes in TSU cells. (F) Generation of CDDP-acquired resistant cells (Ca9-22-R) from Ca9-22 cells. IC50 values are indicated. (G) FACS analysis of the apoptotic cell population among Ca9-22 and Ca9-22-R cells. Cells were transfected with miR-634 (2.5 nM) and treated with CDDP (10 uM) for two days from the following day. (H) Western blot analysis of miR-634 target genes in Ca9-22 and Ca9-22-R cells. In D and G, error bars indicate the SD of triplicate experiments, and data are presented as the mean ± SD. p values were calculated using the two-way ANOVA. ∗p < 0.0001.

    Journal: Molecular Therapy Oncolytics

    Article Title: Potential for reversing miR-634 -mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma

    doi: 10.1016/j.omto.2022.02.002

    Figure Lengend Snippet: Overcoming CDDP resistance by miR-634 in OSCC cells (A) Western blot analysis of miR-634 target genes in RT7 cells and six OSCC cell lines. IC50 values (μM) for CDDP treatment for each cell line are indicated. (B) Quantitative genomic-PCR for the cIAP1 gene in OSCC cell lines. The copy number ratios are presented relative to the copy number in RT7 cells. (C) The correlation between copy number and the corresponding mRNA expression of the cIAP1 gene in 496 cases of HNSCC, including OSCC, from TCGA data. (D) FACS analysis of the apoptotic cell population among TSU cells. Cells were transfected with miRNAs (2.5 nM) and treated with CDDP for two days from the following day. (E) Western blot analysis of cleaved caspase-3 (cCasp-3) and cleaved PARP (cPARP) as the apoptosis markers, and the miR-634 target genes in TSU cells. (F) Generation of CDDP-acquired resistant cells (Ca9-22-R) from Ca9-22 cells. IC50 values are indicated. (G) FACS analysis of the apoptotic cell population among Ca9-22 and Ca9-22-R cells. Cells were transfected with miR-634 (2.5 nM) and treated with CDDP (10 uM) for two days from the following day. (H) Western blot analysis of miR-634 target genes in Ca9-22 and Ca9-22-R cells. In D and G, error bars indicate the SD of triplicate experiments, and data are presented as the mean ± SD. p values were calculated using the two-way ANOVA. ∗p < 0.0001.

    Article Snippet: Among the 1,313 genes, we found cIAP1 , whose expression is involved in chemotherapeutic resistance, including CDDP (listed as BIRC2 in ; FC:5.22 in A431 cells and FC:10.01 in SAS cells).

    Techniques: Western Blot, Expressing, Transfection